申请人:Masarykova univerzita
公开号:EP3556755A1
公开(公告)日:2019-10-23
The invention provides compounds represented by the structural formula (1):
wherein R1, R2, R3, R4, R5, R6 are as defined in the claims. The compounds are inhibitors of nucleases, and are useful in particular in a method of treatment and/or prevention of proliferative diseases, neurodegenerative diseases, and other genomic instability associated diseases.
本发明提供了结构式(1)所代表的化合物:
其中 R1、R2、R3、R4、R5、R6 如权利要求中定义。这些化合物是核酸酶的抑制剂,特别适用于增殖性疾病、神经退行性疾病和其他基因组不稳定性相关疾病的治疗和/或预防方法。